Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Database access restrictions

Database licenses

Data licenses

Data upload

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 16 result(s)
Country
The Alberta Food Composition Database (AFCDB) is the first comprehensive resource on food constituents, chemistry and biology dedicated to major Alberta-grown produce. It provides information on both macronutrients and micronutrients, including many of the constituents that give foods their flavor, color, taste, texture and aroma. Users can view the contents of the AFCDB from the “FoodView” (listing foods by their chemical composition) or the “ChemView” (listing chemicals by their food sources).
<<<!!!<<<The repository is no longer available <<<!!!<<< TOXNET has moved. Most content will continue to be collected and reviewed; selected information is accessible through PubChem, PubMed, and Bookshelf. If you have questions, please contact NLM Customer Support at https://support.nlm.nih.gov/ >>>!!!>>>
Country
The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. The latest release of DrugBank (version 5.1.1, released 2018-07-03) contains 11,881 drug entries including 2,526 approved small molecule drugs, 1,184 approved biotech (protein/peptide) drugs, 129 nutraceuticals and over 5,751 experimental drugs. Additionally, 5,132 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Each DrugCard entry contains more than 200 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data.
GRID-Geneva is a unique platform providing analyses and solutions for a wide range of environmental issues. GRID-Geneva serves primarily the needs of its three institutional partners - UNEP, the Swiss Federal Office for the Environment (FOEN) and the University of Geneva (UniGe) - which are linked by an ongoing, multi-year “Partnership Agreement”, along with other local-to-global stakeholders. GRID-Geneva is also a bilingual English and French centre and the key francophone link within the global GRID network of centres. GRID-Geneva is a key centre of geo-spatial know-how, with strengths in GIS, IP/remote sensing and statistical analyses, integrated through modern spatial data infrastructures and web applications. Working at the interface between scientific information and policy/decision-making, GRID-Geneva also helps to develop capacities in these fields of expertise among target audiences, countries and other groups.
Content type(s)
CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health. It provides manually curated information about chemical–gene/protein interactions, chemical–disease and gene–disease relationships. These data are integrated with functional and pathway data to aid in development of hypotheses about the mechanisms underlying environmentally influenced diseases. We also have additional ongoing projects involving manual curation of exposome data and chemical–phenotype relationships to help identify pre–disease biomarkers resulting from environmental exposures. The initial release of CTD was on November 12, 2004. We’re grateful to our strong community support and encourage you to give us feedback so we can continue to evolve with your research needs.
Country
The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. It is intended to be used for applications in metabolomics, clinical chemistry, biomarker discovery and general education.
Country
<<<!!!<<< ----This page has been archived on the Web--- >>>!!!>>> Environment and Climate Change Canada collects biological samples from a number of lakes and rivers across Canada in support of federally mandated programs. Environment and Climate Change Canada has collected fish and invertebrates from the Great Lakes since 1977 in support of the Great Lakes Water Quality Agreement (GLWQA). More recently, samples have been collected nationally to support Canada's Chemicals Management Plan and the Clean Air Regulatory Agenda. Environment and Climate Change Canada also maintains a specimen bank of frozen tissues which is a requirement of the GLWQA and is an integral part of departmental monitoring and research programs. The National Aquatic Biological Specimen Bank (NABSB) is located in a dedicated facility at the Canada Centre for Inland Waters in Burlington, Ontario. The NABSB holds more than 37,000 samples of fish and invertebrates collected over the last 30+ years of environmental monitoring in Canada. Research conducted using samples from the NABSB has produced more than 60 scientific publications, reports and book chapters
Country
The mission of the platform is to enable access for academic projects towards experiments in high-throughput without loss of IP and on a cost basis, which does not restrict access towards HTS usage. The FMP hosts the central open access technology platform of EU-OPENSCREEN, the ChemBioNet and theHelmholtz-Initiative für Wirkstoffforschung, the Screening Unit. The Unit serves for systematic screening of large compound or genome-wide RNAi libraries with state-of-the-art equipment like automated microscopes and microfluidic systems. The Screening Unit is part of the Chemical Biology Platform of the FMP also supported by the MDC. See also: https://www.mdc-berlin.de/screening-unit